Could Cannabinoids Help Combat COVID-19?
Tetra Bio-Pharma will start Phase 1 testing for AARDS-003, their new, THC-free, cannabinoid drug for COVID-19 patients.
Tetra Bio-Pharma will start Phase 1 testing for AARDS-003, their new, THC-free, cannabinoid drug for COVID-19 patients.
With cannabis prohibition on the decline, it’s a great time for innovators to create new technology to improve how people cultivate and consume cannabis.
